Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508
暂无分享,去创建一个
Y. Kagami | M. Ogura | T. Kinoshita | K. Tobinai | K. Itoh | K. Tsukasaki | T. G. S. Group | T. Chou | T. Hotta | K. Mukai | M. Shimoyama | N. Fukushima | Takayo Suzuki | H. Fukuda | Tsuneo Sasaki | C. Mikuni | Yuko Watanabe | Y. Kiyama